LTF and neoplasm: However, considering its known low bioavailability [47], whether oral administration of Lf (either from human or bovine origin) will be successful in promoting its delivery to the tumor site and, consequently, its interaction with V-ATPase is still an important open question that should be pursued to validate V-ATPase as a biomarker and to boost Lf use in therapies.